Suppr超能文献

布拉氏酵母菌治疗儿童急性腹泻:一项随机、安慰剂对照研究。

Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study.

作者信息

Villarruel Gladys, Rubio Daniel Martinez, Lopez Fani, Cintioni Julio, Gurevech Rubén, Romero Gladis, Vandenplas Yvan

机构信息

Hospital Privado Materno Infantil, National University of Salta, Campo Castañares, Salta, Argentina.

出版信息

Acta Paediatr. 2007 Apr;96(4):538-41. doi: 10.1111/j.1651-2227.2007.00191.x. Epub 2007 Feb 14.

Abstract

OBJECTIVE

To evaluate the efficacy of the probiotic yeast Saccharomyces boulardii (S. boulardii) as an adjuvant to oral rehydration solution (ORS) in shortening the duration of acute infectious gastroenteritis in children less than 2 years old in ambulatory care.

MATERIALS AND METHODS

In a period of 1 year, 100 outpatients between 3 and 24 months old presenting with acute mild to moderate diarrhoea of less than 7 days duration, were included in a double-blind, randomized, placebo-controlled trial evaluating the efficacy of S. boulardii administered for 6 days. Twelve children were lost in follow-up; the data of 88 children could be analysed (44 in the placebo and 44 in the S. boulardii group). Seventy-two patients were followed for one month (37 in the placebo and 35 in the S. boulardii group) allowing the calculation of the duration of diarrhoea.

RESULTS

The mean duration of diarrhoea was 6.16 days (range 2-13 days) in the placebo group and 4.70 days (range 2-10 days) in the S. boulardii group (p<0.05). On the 4th day, the patients in the S. boulardii group passed 2.5+/-1.4 stools/day versus 3.5+/-1.8 in the placebo group (p<0.001). The risk of having diarrhoea lasting more than 7 days was lower in the S. boulardii group (3/44 versus 12/44; RR 0.25; 95% CI 0.1-0.8). In no patient diarrhoea persisted longer than 14 days. A statistically significant difference was observed in the number of stools on the 4th and 7th day favouring the subgroup that received early treatment (within the first 48 h of the onset of diarrhoea). The administration of antibiotics before inclusion did not make any difference.

CONCLUSION

S. boulardii as an adjuvant to ORS in ambulatory care in children less than 2 years old with mild or moderate acute diarrhoea decreased the duration of diarrhoea, accelerated recovery and reduced the risk of prolonged diarrhoea. The data also indicate increased efficacy if S. boulardii is administered within the first 48 h of the onset of diarrhoea.

摘要

目的

评估益生菌酵母布拉酵母菌(S. boulardii)作为口服补液盐(ORS)辅助剂,在门诊治疗中缩短2岁以下儿童急性感染性胃肠炎病程的疗效。

材料与方法

在1年的时间里,100名年龄在3至24个月、患有持续时间少于7天的急性轻至中度腹泻的门诊患者,被纳入一项双盲、随机、安慰剂对照试验,以评估服用6天布拉酵母菌的疗效。12名儿童失访;88名儿童的数据可进行分析(安慰剂组44名,布拉酵母菌组44名)。72名患者随访1个月(安慰剂组37名,布拉酵母菌组35名),以便计算腹泻持续时间。

结果

安慰剂组腹泻平均持续时间为6.16天(范围2 - 13天),布拉酵母菌组为4.70天(范围2 - 10天)(p<0.05)。第4天,布拉酵母菌组患者每日排便2.5±1.4次,而安慰剂组为3.5±1.8次(p<0.001)。布拉酵母菌组腹泻持续超过7天的风险较低(3/44对12/44;RR 0.25;95% CI 0.1 - 0.8)。没有患者腹泻持续超过14天。在第4天和第7天的排便次数上观察到统计学上的显著差异,有利于接受早期治疗(腹泻发作后48小时内)的亚组。纳入前使用抗生素没有任何差异。

结论

在门诊治疗2岁以下患有轻至中度急性腹泻的儿童时,布拉酵母菌作为ORS的辅助剂可缩短腹泻持续时间,加速康复并降低腹泻持续时间延长的风险。数据还表明,如果在腹泻发作后的48小时内给予布拉酵母菌,疗效会增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验